Summary of Addus HomeCare Conference Call Company Overview - **Company**: Addus HomeCare (NasdaqGS:ADUS) - **Industry**: Personal Care Services - **States of Operation**: 22 states in the U.S. [2] Core Business Segments - **Personal Care**: Represents approximately 75% of the business - **Clinical Services**: Comprises about 20% of the business, primarily hospice - **Home Health**: Accounts for 5% of the business [4] Growth Strategy - **Acquisition Target**: Aiming for 10% annual growth, with half from acquisitions [6] - **Recent Acquisition**: Acquired Gentiva's personal care business, becoming the largest provider in Texas and Arkansas, expanding into seven states [6] - **Market Position**: Currently holds 5% market share in Texas, indicating significant growth potential [7] Financial Performance - **Organic Growth**: Historically, personal care has a long-term growth rate of 3% to 5%, with recent performance exceeding this due to rate increases and volume growth [10] - **Rate Increases**: Texas experienced a nearly 20% rate increase, with Illinois also providing strong support [10] - **Future Projections**: Anticipates maintaining or exceeding 3% to 5% growth in personal care, with hospice growth around 10% [12][14] Challenges and Opportunities - **Redeterminations Impact**: Experienced delays in admissions due to state agencies reallocating resources for Medicaid redeterminations, but expects normalization by 2026 [25][30] - **Labor Environment**: The company is seeing stable hiring metrics and wage inflation returning to historical norms of around 3% [42][44] Technology and Integration - **Technology Adoption**: Implementing a caregiver app to enhance communication and efficiency, with a goal of 90% participation in Illinois [39] - **Integration of Gentiva**: The integration process is progressing smoothly, with plans to transition Gentiva to a unified electronic medical record (EMR) system by late 2026 [33][34] Medicaid and State Relations - **Value Proposition**: Emphasizes the cost-effectiveness of home care versus nursing homes, advocating for continued state support [15][16] - **Managed Medicaid Strategy**: Focus on building relationships with managed care organizations to negotiate rates and improve service delivery [20][22] Investor Insights - **Underappreciated Aspects**: The potential positive impact of Medicaid changes and work requirements on the company's operations, positioning Addus as a cost-saving solution for states [54][55] Conclusion - **Overall Outlook**: Addus HomeCare is well-positioned for growth through strategic acquisitions, technology integration, and strong state relationships, with a focus on maintaining quality care while navigating challenges in the Medicaid landscape [56]

Company Overview - Addus HomeCare Corporation (ADUS) is currently experiencing significant activity in the options market, particularly with the Oct 17, 2025 $130 Call option showing high implied volatility, indicating potential for a major price movement [1] - The company holds a Zacks Rank 3 (Hold) in the Medical - Outpatient and Home Healthcare industry, which is positioned in the top 35% of the Zacks Industry Rank [3] Analyst Insights - Over the past 60 days, one analyst has raised the earnings estimate for the current quarter from $1.52 to $1.53 per share, while no analysts have lowered their estimates, suggesting a positive outlook [3] - The high implied volatility in options trading may signal that traders are anticipating a significant price movement for Addus HomeCare shares, which could indicate a developing trading opportunity [4] Options Trading Strategy - Options traders often seek out options with high implied volatility to sell premium, a strategy that can capture decay and potentially reduce risk if the underlying stock does not move as much as expected [4]

Core Insights - The Zacks Medical - Outpatient and Home Healthcare industry is experiencing a significant shift towards digital healthcare, driven by rising demand for telemedicine and AI-powered services, particularly due to an aging global population and increasing healthcare costs [1][4][10] Industry Overview - The industry includes companies providing outpatient care using advanced medical technologies for diagnosis, treatment, and rehabilitation, with a focus on innovation and value-based care models [3] - The global home healthcare market was valued at $416.4 billion in 2024 and is projected to reach $747.70 billion by 2030, growing at a CAGR of approximately 10.2% [1] Major Trends - Aging Population: The growing elderly population is a primary driver for home healthcare services, as older individuals prefer receiving care in familiar home settings [4] - Cost Effectiveness: Outpatient clinics offer cost-effective care, reducing the financial burden on patients and healthcare systems [5] - AI's Role: AI enhances patient care through remote monitoring and data analysis, facilitating timely interventions and improving care management [7] - Technological Advancements: Virtual assistants and chatbots are increasingly used to assist patients in managing their care and appointments [8] Staffing Challenges - The U.S. healthcare industry faces severe staffing shortages, particularly among home health aides, exacerbated by high burnout rates and international migration of health workers [11] Market Performance - The industry has underperformed compared to the S&P 500, losing 0.5% over the past year, while the S&P 500 rose by 18.2% [14] - The industry's current valuation is at a forward P/E of 19.6X, compared to the S&P 500's 23.4X [18] Company Highlights - **Quest Diagnostics**: Anticipates 2025 revenue growth of 9.9% and earnings growth of 9.1%, with a current ROE of 15.2% [21][22][25] - **DaVita**: Expected revenue growth of 5% and earnings growth of 12.9% for 2025, with an impressive ROE of 369.4% [26][27][30] - **Addus HomeCare**: Forecasts a 21.5% increase in revenues and a 16.5% rise in earnings for 2025, with a ROE of 9.4% [31][32][34] - **The Pennant Group**: Projects a 26.5% growth in revenues and a 21.3% increase in earnings for 2025, with a ROE of 9.9% [35][36][37]

Core Viewpoint - Addus HomeCare Corporation will participate in the Jefferies 2025 Healthcare Services Conference, indicating its engagement with industry stakeholders and potential for future growth [1] Company Participation - Dirk Allison, Chairman and CEO, and Brian Poff, Executive Vice President and CFO, will represent the company at the conference [1] - The event is scheduled for September 29 - 30, 2025, in Nashville, Tennessee [1] Presentation Details - There will be a live broadcast and replay of the company's presentation during the conference [1]

Group 1 - TimesSquare Capital Management's "U.S. Small Cap Growth Strategy" reported a gross return of 11.28% and a net return of 11.02% in Q2 2025, underperforming the Russell 2000 Growth Index which returned 11.97% [1] - The fund's performance was attributed to double-digit returns in equities driven by global economic activity [1] - The top five holdings of the fund were highlighted as key picks for 2025 [1] Group 2 - Addus HomeCare Corporation (NASDAQ:ADUS) provides personal care services and reported a one-month return of -2.37% and a 52-week loss of 13.64% [2] - As of September 11, 2025, Addus HomeCare's stock closed at $112.38 with a market capitalization of $2.069 billion [2] - In Q2 2025, Addus HomeCare reported total revenue of $349.4 million, marking a 21.8% increase compared to Q2 2024 [4] Group 3 - TimesSquare Capital expressed a preference for Health Care stocks that provide novel therapies or specialized services, noting Addus HomeCare's 16% rise due to solid Q1 results [3] - The personal care segment of Addus HomeCare is highlighted as a bright spot, benefiting from stable volumes and favorable rate increases [3] - Despite the potential of Addus HomeCare, the company is not among the 30 most popular stocks among hedge funds, with 16 hedge fund portfolios holding its stock at the end of Q2 2025, down from 24 in the previous quarter [4]

Core Viewpoint - Addus HomeCare Corporation (NASDAQ: ADUS) is perceived as a "show me" story, with its Q2 '25 numbers reinforcing this perspective [1] Financial Performance - The company's recent financial results indicate a need for further validation of its growth narrative [1] Investment Sentiment - The stock is under scrutiny, with investors looking for clear evidence of sustainable performance before committing [1]

[PART I. FINANCIAL INFORMATION](index=4&type=section&id=PART%20I.%20FINANCIAL%20INFORMATION) This section presents the company's unaudited condensed consolidated financial statements and management's discussion and analysis for the period ended June 30, 2025 [Item 1. Financial Statements](index=4&type=section&id=Item%201.%20Financial%20Statements) The unaudited condensed consolidated financial statements for Addus HomeCare Corporation as of June 30, 2025, show year-over-year growth in revenues and net income [Condensed Consolidated Balance Sheets](index=4&type=section&id=Condensed%20Consolidated%20Balance%20Sheets) Total assets slightly decreased to $1.409 billion as of June 30, 2025, while total liabilities decreased, increasing stockholders' equity to $1.022 billion Condensed Consolidated Balance Sheet Highlights | Account | June 30, 2025 (in thousands) | December 31, 2024 (in thousands) | | :--- | :--- | :--- | | **Total Current Assets** | $263,045 | $260,382 | | **Total Assets** | **$1,408,931** | **$1,412,634** | | **Total Current Liabilities** | $151,383 | $155,871 | | **Total Liabilities** | **$387,077** | **$442,142** | | **Total Stockholders' Equity** | **$1,021,854** | **$970,492** | [Condensed Consolidated Statements of Income](index=5&type=section&id=Condensed%20Consolidated%20Statements%20of%20Income) For Q2 2025, net service revenues grew 21.8% to $349.4 million, with net income increasing 22.0% to $22.1 million and diluted EPS reaching $1.20 Consolidated Income Statement Summary | Metric | Q2 2025 (in thousands) | Q2 2024 (in thousands) | % Change | H1 2025 (in thousands) | H1 2024 (in thousands) | % Change | | :--- | :--- | :--- | :--- | :--- | :--- | :--- | | Net Service Revenues | $349,443 | $286,922 | 21.8% | $687,151 | $567,668 | 21.0% | | Gross Profit | $113,877 | $93,158 | 22.2% | $221,554 | $181,335 | 22.2% | | Operating Income | $32,887 | $26,181 | 25.6% | $63,401 | $49,826 | 27.2% | | Net Income | $22,052 | $18,079 | 22.0% | $43,280 | $33,909 | 27.6% | | Diluted EPS | $1.20 | $1.10 | 9.1% | $2.36 | $2.06 | 14.6% | [Condensed Consolidated Statements of Cash Flows](index=8&type=section&id=Condensed%20Consolidated%20Statements%20of%20Cash%20Flows) Net cash provided by operating activities for H1 2025 decreased to $41.5 million, while net cash used in financing activities was $49.5 million, driven by debt repayment Cash Flow Summary for the Six Months Ended June 30 | Activity | 2025 (in thousands) | 2024 (in thousands) | | :--- | :--- | :--- | | Net cash provided by operating activities | $41,478 | $57,491 | | Net cash used in investing activities | $317 | $1,798 | | Net cash (used in) provided by financing activities | ($49,530) | $49,225 | | **Net change in cash** | **($7,735)** | **$108,514** | [Notes to Condensed Consolidated Financial Statements](index=9&type=section&id=Notes%20to%20Condensed%20Consolidated%20Financial%20Statements) The notes detail operations, accounting policies, and key financial events, including divestitures, acquisitions, credit facility, and revenue breakdown by segment and payor - The company operates three business segments: Personal Care (non-medical assistance), Hospice (end-of-life care), and Home Health (skilled medical care)[20](index=20&type=chunk) - Effective May 20, 2024, the company agreed to sell its New York operations for up to **$23.0 million**, resulting in deconsolidation and a gain recognition in 2024[29](index=29&type=chunk) - In Q1 2025, the company completed two personal care acquisitions: Jacksonville for **$0.8 million** and Great Lakes Home Care for **$2.6 million**, adding **$3.4 million** in goodwill[38](index=38&type=chunk)[39](index=39&type=chunk) - As of June 30, 2025, the company had **$173.0 million** outstanding on its **$650.0 million** revolving credit facility, with an interest rate of **6.07%**[49](index=49&type=chunk)[56](index=56&type=chunk) - The Illinois Department on Aging is a significant payor, accounting for **18.6%** of net service revenues for the six months ended June 30, 2025[73](index=73&type=chunk) - Subsequent to the quarter end, on August 1, 2025, the company acquired Helping Hands Home Care Service in Pennsylvania for approximately **$21.3 million**[77](index=77&type=chunk) [Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations](index=23&type=section&id=Item%202.%20Management's%20Discussion%20and%20Analysis%20of%20Financial%20Condition%20and%20Results%20of%20Operations) Management attributes 21.0% revenue growth to the Gentiva acquisition and organic hospice growth, detailing segment performance, regulatory impacts, and strong liquidity [Overview and Recent Developments](index=23&type=section&id=Overview%20and%20Recent%20Developments) The company provides in-home care across 23 states, with growth driven by strategic acquisitions like Gentiva and smaller Q1 2025 deals, alongside the divestiture of New York operations - The Gentiva Acquisition, completed in December 2024 for approximately **$350.6 million**, significantly expanded the company's personal care segment and facilitated entry into Missouri and Texas[85](index=85&type=chunk) - In Q1 2025, the company completed the Jacksonville Acquisition for **$0.8 million** and the Great Lakes Acquisition for **$2.6 million**, further expanding its personal care segment[86](index=86&type=chunk)[87](index=87&type=chunk) [Regulatory and Policy Environment](index=28&type=section&id=Regulatory%20and%20Policy%20Environment) Government reimbursement policies significantly influence performance, with approved rate increases in Illinois, Medicare hospice rate increases, and potential impacts from the CMS '80/20' rule and OBBBA - Illinois approved an increase in hourly rates for in-home care services to **$29.63**, effective January 1, 2025, with a further increase to **$30.80** in the fiscal 2026 budget[97](index=97&type=chunk)[98](index=98&type=chunk) - Effective October 1, 2024, CMS increased Medicare hospice payment rates by **2.9%**[102](index=102&type=chunk) - CMS finalized the '80/20' rule, requiring states to ensure at least **80%** of Medicaid payments for certain home care services are spent on direct care worker compensation by mid-2030[108](index=108&type=chunk) - The company is evaluating the impact of the 'One Big Beautiful Bill Act' (OBBBA), which is expected to result in significant cuts to federal healthcare spending, particularly Medicaid[111](index=111&type=chunk)[112](index=112&type=chunk) [Results of Operations — Consolidated](index=32&type=section&id=Results%20of%20Operations%20%E2%80%94%20Consolidated) Consolidated results show strong top- and bottom-line growth, with Q2 2025 net service revenues increasing **21.8%** to **$349.4 million** and net income growing **22.0%** to **$22.1 million** Consolidated Results for the Three Months Ended June 30 | Metric (in thousands) | 2025 | 2024 | % Change | | :--- | :--- | :--- | :--- | | Net service revenues | $349,443 | $286,922 | 21.8% | | Gross profit | $113,877 | $93,158 | 22.2% | | Operating income | $32,887 | $26,181 | 25.6% | | Net income | $22,052 | $18,079 | 22.0% | [Results of Operations – Segments](index=34&type=section&id=Results%20of%20Operations%20%E2%80%93%20Segments) Segment performance was led by Personal Care's **26.5%** revenue increase, Hospice's **10.0%** organic growth, and Home Health's nearly doubled operating income due to margin improvements Personal Care Segment Key Metrics (Q2 2025 vs Q2 2024) | Metric | Q2 2025 (in millions) | Q2 2024 (in millions) | % Change | | :--- | :--- | :--- | :--- | | Net Service Revenues | $269.2M | $212.8M | 26.5% | | Segment Operating Income | $51.6M | $43.1M | 19.8% | | Average Billable Census | 50,404 | 37,993 | 32.7% | | Revenues per Billable Hour | $25.49 | $27.47 | (7.2)% | Hospice Segment Key Metrics (Q2 2025 vs Q2 2024) | Metric | Q2 2025 (in millions) | Q2 2024 (in millions) | % Change | | :--- | :--- | :--- | :--- | | Net Service Revenues | $62.2M | $56.0M | 11.0% | | Segment Operating Income | $14.8M | $12.8M | 15.5% | | Average Daily Census | 3,720 | 3,477 | 7.0% | | Organic Revenue Growth | 10.0% | 6.3% | 3.7 p.p. | Home Health Segment Key Metrics (Q2 2025 vs Q2 2024) | Metric | Q2 2025 (in millions) | Q2 2024 (in millions) | % Change | | :--- | :--- | :--- | :--- | | Net Service Revenues | $18.0M | $18.1M | (0.1)% | | Segment Operating Income | $4.4M | $2.2M | 97.0% | | Gross Profit % | 45.9% | 37.6% | 8.3 p.p. | [Liquidity and Capital Resources](index=39&type=section&id=Liquidity%20and%20Capital%20Resources) The company maintains strong liquidity with **$91.2 million** in cash and **$454.6 million** available under its credit facility, despite decreased operating cash flow due to working capital changes - As of June 30, 2025, the company had a cash balance of **$91.2 million**[157](index=157&type=chunk) - The company had **$173.0 million** in revolving loans outstanding and **$454.6 million** available for borrowing under its credit facility[158](index=158&type=chunk) - Net cash from operating activities for H1 2025 was **$41.5 million**, down from **$57.5 million** in H1 2024, primarily due to the timing of receipts on accounts receivable[166](index=166&type=chunk) - Days Sales Outstanding (DSO) was **38 days** at June 30, 2025, compared to **39 days** at December 31, 2024[170](index=170&type=chunk) [Item 3. Quantitative and Qualitative Disclosures About Market Risk](index=42&type=section&id=Item%203.%20Quantitative%20and%20Qualitative%20Disclosures%20About%20Market%20Risk) The company's primary market risk is interest rate risk on its variable-rate long-term debt, where a **100 basis point** increase would decrease H1 2025 net income by approximately **$0.8 million** - The company's primary market risk is interest rate risk on its **$173.0 million** of variable-rate debt[175](index=175&type=chunk) - A **100 basis point** increase in interest rates would have reduced H1 2025 net income by **$0.8 million**[175](index=175&type=chunk) [Item 4. Controls and Procedures](index=42&type=section&id=Item%204.%20Controls%20and%20Procedures) Management concluded that disclosure controls and procedures were effective as of June 30, 2025, with no material changes to internal control over financial reporting during the quarter - The CEO and CFO concluded that the company's disclosure controls and procedures were effective as of the end of the quarter[177](index=177&type=chunk) - No material changes in internal control over financial reporting were identified during the quarter ended June 30, 2025[178](index=178&type=chunk) [PART II. OTHER INFORMATION](index=43&type=section&id=PART%20II.%20OTHER%20INFORMATION) This section covers legal proceedings, risk factors, and other required disclosures, confirming no material changes or significant events for the reporting period [Item 1. Legal Proceedings](index=43&type=section&id=Item%201.%20Legal%20Proceedings) The company is subject to various legal and administrative proceedings, but management believes their outcomes will not materially affect its financial position or results - Management does not expect pending legal proceedings to have a material impact on the company's financial condition[180](index=180&type=chunk) [Item 1A. Risk Factors](index=43&type=section&id=Item%201A.%20Risk%20Factors) No material changes to the risk factors previously disclosed in the company's Annual Report on Form 10-K for the year ended December 31, 2024, were reported - No material changes to the company's risk factors were reported for the quarter[181](index=181&type=chunk) [Other Part II Items](index=43&type=section&id=Other%20Part%20II%20Items) The report indicates no unregistered sales of equity securities, no defaults upon senior securities, no mine safety disclosures, and no other material information - The company reported no activity for Item 2 (Unregistered Sales of Equity Securities), Item 3 (Defaults Upon Senior Securities), Item 4 (Mine Safety Disclosures), and Item 5 (Other Information)[182](index=182&type=chunk)[183](index=183&type=chunk)[184](index=184&type=chunk)[185](index=185&type=chunk)

Financial Data and Key Metrics Changes - Total revenue for Q2 2025 was $349.4 million, an increase of 21.8% compared to $286.9 million in Q2 2024 [6] - Adjusted earnings per share rose to $1.49, up 10.4% from $1.35 in the previous year [6] - Adjusted EBITDA increased by 24.5% to $43.9 million from $35.3 million in Q2 2024 [6][20] - Cash on hand as of June 30, 2025, was approximately $91 million, with a reduction in bank debt by $30 million to a total of $173 million [6][28] Business Line Data and Key Metrics Changes - Personal Care segment revenues were $269.2 million, accounting for 77% of total revenue, with a same-store revenue growth of 7.4% [25][14] - Hospice segment revenues were $62.2 million, representing 17.8% of total revenue, with a same-store revenue growth of 10% [25][15] - Home Health segment revenues were $18 million, making up 5.2% of total revenue, with a same-store revenue decrease of 6% [25][16] Market Data and Key Metrics Changes - Illinois and Texas have finalized budget increases for personal care services, with Illinois set to increase reimbursement rates by 3.9% effective January 1, 2026, and Texas by 9.9% effective September 1, 2025 [10][22] - The Illinois rate increase is expected to add approximately $17.5 million in annualized revenue, while the Texas increase is projected to add about $17.7 million [10][22] Company Strategy and Development Direction - The company continues to focus on strategic acquisitions to enhance geographic coverage and clinical services, with the recent acquisition of Helping Hands Home Care in Pennsylvania [17][24] - The company aims to maintain a conservative net leverage position to pursue further acquisition opportunities [6][29] - The focus remains on organic growth complemented by acquisitions, particularly in personal care and hospice services [24][29] Management's Comments on Operating Environment and Future Outlook - Management expressed optimism regarding the reimbursement environment, noting strong support for personal care services from state budgets [33] - Concerns were raised about potential reductions in Medicare payments for home health services, which could impact availability and access to care [12][13] - The company believes that the value of home-based care will continue to be recognized, providing growth opportunities [18] Other Important Information - The company has experienced consistent cash collections and a reduction in bank debt, supporting its capital structure for future investments [28][29] - The adjusted net income per diluted share for Q2 2025 was $1.49, reflecting a solid financial performance [27] Q&A Session Summary Question: How is the overall reimbursement environment expected to unfold? - Management noted strong support from larger markets and expressed optimism about future rate increases, despite some states delaying discussions due to budget uncertainties [32][34] Question: What is driving the negative volumes in same-store census? - The decrease was attributed to the inclusion of New York in prior year comparisons, which has since been disposed of, and a sequential increase in same-store census was noted [35][36] Question: How is the caregiver application rollout impacting performance? - The caregiver application has seen good adoption in Illinois, with about 90% of caregivers registered, and is expected to improve fill rates and retention over time [42][45] Question: What is the impact of immigration policy changes on the workforce? - Currently, there is no significant impact observed, as the company has a small number of caregivers affected by immigration policies [51][52] Question: What are the expectations for hospice segment growth? - Long-term growth expectations for the hospice segment are projected to be in the 5% to 7% range, with recent operational improvements contributing to current growth [53][54] Question: What are the public advocacy priorities for the company? - The company is focused on advocating for the value of personal care services and addressing concerns regarding proposed Medicare payment reductions [81][84] Question: How are payer contracts evolving? - Discussions with payers are increasingly focused on driving volume into plans, with ongoing efforts to implement case rate or episodic payment structures in home health [85][86]

Core Insights - Addus HomeCare reported strong Q2 2025 financial results, with revenue and earnings exceeding Wall Street estimates, driven by organic growth and acquisitions [1][2] Financial Performance - Q2 2025 GAAP revenue was $349.4 million, surpassing the estimate of $346.5 million, and reflecting a 21.8% increase from Q2 2024 [2] - Non-GAAP earnings per share reached $1.49, exceeding the consensus of $1.47 and marking a 10.4% year-over-year growth [2] - Adjusted EBITDA was $43.9 million, up 24.4% from $35.3 million in Q2 2024 [2] - Net income increased to $22.1 million, a 22.1% rise from $18.1 million in the previous year [2] - Cash flow from operations was $22.5 million, a 19.7% increase from $18.8 million in Q2 2024 [2] Business Overview - Addus HomeCare operates in 23 states, focusing on personal care, hospice care, and home health services [3] - Personal care services account for 77% of total revenue, with a year-over-year growth of 26.5% [5] - Hospice services contributed 17.8% of revenue, showing a 10.0% organic growth rate [6] - Home health services represented 5.2% of overall revenue, with a slight decline year-over-year [7] Strategic Initiatives - The company aims for organic growth through increased service volumes and rates, alongside strategic acquisitions [4] - Recent acquisitions, including Gentiva Personal Care Services, have enhanced market coverage and service density [5][8] - Technology adoption is progressing, with a caregiver scheduling app being rolled out to improve operational efficiency [8] Market Outlook - The company anticipates robust demand for home-based care and continues to focus on operational efficiency and accretive acquisitions [9] - Organic revenue growth in Personal Care exceeded the long-term target range of 3-5% [9] - Management is closely monitoring government reimbursement rates and regulatory developments, as most revenue is derived from Medicaid and Medicare [10]

Core Insights - Addus HomeCare reported revenue of $349.44 million for the quarter ended June 2025, reflecting a year-over-year increase of 21.8% and a surprise of +0.4% over the Zacks Consensus Estimate of $348.04 million [1] - The company's EPS for the quarter was $1.49, up from $1.35 in the same quarter last year, resulting in an EPS surprise of +2.76% compared to the consensus estimate of $1.45 [1] Revenue Breakdown - Personal Care revenue reached $269.18 million, exceeding the two-analyst average estimate of $265.88 million, with a year-over-year increase of +26.5% [4] - Home Health revenue was reported at $18.05 million, slightly below the two-analyst average estimate of $18.26 million, showing a year-over-year change of -0.2% [4] - Hospice revenue amounted to $62.21 million, surpassing the average estimate of $61.32 million from two analysts, with a year-over-year increase of +11% [4] Stock Performance - Over the past month, Addus HomeCare shares have returned -6.2%, contrasting with the Zacks S&P 500 composite's +0.6% change [3] - The stock currently holds a Zacks Rank 3 (Hold), indicating potential performance in line with the broader market in the near term [3]